EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

UBD‐mediated glycolytic reprogramming promotes M2 macrophage polarization in ovarian cancer immune evasion

Nana Zhang, Fengming Zhao, Hailong Chen, Juli Wang, Haiyan Li iD

Journal of Cell Communication and Signaling · 2025-09 · 19 (3)

DOI: 10.1002/ccs3.70034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Communication and Signaling, online erschienen am 21.07.2025. Verfasst von Nana Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics Department of Shijiazhuang People's Hospital Shijiazhuang China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) is one of the most common malignant tumors in women, with immunotherapy resistance (ITR) being a major challenge. Glycolytic metabolic reprogramming has been shown to play a crucial role in the tumor immune microenvironment and immune evasion, yet the underlying mechanisms remain unclear. This study aims to investigate the role of Ubiquitin D (UBD) in OC immunotherapy, particularly its regulation of macrophage polarization through glycolytic metabolism. Using data from the Cancer Genome Atlas and Clinical Proteomic Tumor Analysis Consortium databases, combined with proteomics techniques, we analyzed the expression of UBD in OC tissues and its correlation with key glycolytic enzymes. Through lentiviral‐mediated gene manipulation and in vivo mouse models, we evaluated the effects of UBD on macrophage polarization, glycolytic metabolism, and immunotherapy. The results indicate that UBD promotes M2 macrophage polarization through glycolytic reprogramming, enhancing immune evasion and ITR in OC. Inhibiting UBD or targeting glycolytic pathways may provide new strategies for improving OC immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

glycolytic metabolismimmunotherapy resistancemacrophage polarizationovarian cancertumor microenvironmentubiquitin D

Autor:innen und Institutionen

  • Obstetrics Department of Shijiazhuang People's Hospital Shijiazhuang China.
  • Department of Neurosurgery The Third Hospital of Shijiazhuang Shijiazhuang China.
  • Gynecology Department of Shijiazhuang People's Hospital Shijiazhuang China.

ORCID-Profile: Haiyan Li

Zitieren

APA

Zhang, N., Zhao, F., Chen, H., Wang, J., & Li, H. (2025). UBD‐mediated glycolytic reprogramming promotes M2 macrophage polarization in ovarian cancer immune evasion. Journal of Cell Communication and Signaling, 19(3). https://doi.org/10.1002/ccs3.70034

Vancouver

Zhang N, Zhao F, Chen H, Wang J, Li H. UBD‐mediated glycolytic reprogramming promotes M2 macrophage polarization in ovarian cancer immune evasion. Journal of Cell Communication and Signaling. 2025;19(3). doi:10.1002/ccs3.70034

BibTeX
@article{Zhang2025,
  author = {Zhang, Nana and Zhao, Fengming and Chen, Hailong and Wang, Juli and Li, Haiyan},
  title = {UBD‐mediated glycolytic reprogramming promotes M2 macrophage polarization in ovarian cancer immune evasion},
  journal = {Journal of Cell Communication and Signaling},
  year = {2025},
  volume = {19},
  number = {3},
  doi = {10.1002/ccs3.70034}
}
Kostenlos starten →